Approval Of Allergen's New Natrelle Inspira Extra Cohesive Breast Implant
Allergan Announces FDA Approval
Allergan Pharmaceuticals continues to make great stride in increased enhancement of their already excellent technology with silicone and saline breast implants. Currently, on September 23, 2016, the FDA has now once again approved their newest silicone gel implant, the Inspira Natrelle Extra Cohesive Silicone Gel Implant. This implant has increased gel cohesiveness with a round implant with an extra high gel fill ratio.
This is especially useful in my practice as a specialist in breast reconstruction revision surgery. Patients present with thin tissue after multiple reconstruction revision and having this extra cohesive silicone gel smooth implant will greatly reduce the need for ADM graft material and reduce visibility in revision patients. The cohesive breast implants offer women both reconstruction augmentation or revision surgery options with a combined high gel-fill ratio for customized results. This new implant allows patients to get the same high gel-fill ratio and fullness offered by Natrelle Inspira lines of implants with their most highly cohesive foam silicone gel. The FDA has now approved this with both smooth and bio-filled textured surfaces in the round shape implants. The smooth version of Natrelle Inspira round gel filled breast implants was approved by the FDA back in February 2015.
This silicone gel implant is considered one of the finest implants ever created. We are very much looking forward to using the new Inspira SRX and SRF Extra Cohesive Gel Implants by Allergan Pharmaceuticals.